ALNEV to 0.05 after the recent news? EURONEXT:ALNEV
Trading at range lows. Very risky and that's why a tight stop loss.
#DYOR #NotAnInvestmentAdvice
0W8U trade ideas
Neovacs - strong bullish trend expectedResults of IFN Kinoide on Lupus research are very significant (95% efficacy observed). Volume increase strongly on the biotech and strong breakout of the 0.25 resistance has been observed. Pullback on the 0.25 level is resolved and the stock is now in perfect conditions for a bullish rally. First target is 0.5
